Results 171 to 180 of about 259,590 (298)

Carbohydrate‐Based Drug Discovery: Synthetic Strategies and Clinical Applications

Israel Journal of Chemistry, Volume 66, Issue 3, May 2026.
The picture depicts the molecules discussed in the review. On the left side, the general scaffold of sugars is shown. Next to it are four carbohydrate‐based molecules, including remdesivir, islatravir, empagliflozin, and Globo‐H. Remdesivir and islatravir contain a substituted ribose ring attached to a modified nucleobase.
Stephan Scheeff, Jemma Arakelyan, Billy Wai‐Lung Ng   +2 more
wiley   +1 more source

Adherence to antiretroviral therapy among female sex workers in Kampala, Uganda. [PDF]

J Public Health Afr
Ssemakula DM, Balinda SN, Mayanja Y, Kamacooko O, Abaasa A, Seeley J.   +5 more
europepmc   +1 more source

Evaluation of Relative Bioavailability and Food Effect of a Fixed‐Dose Combination Tablet of Islatravir and Lenacapavir

The Journal of Clinical Pharmacology, Volume 66, Issue 5, May 2026.
Abstract Long‐acting oral HIV‐1 treatments can potentially reduce pill burden, treatment fatigue, suboptimal adherence, and treatment failure. A combination of islatravir, a nucleoside reverse transcriptase translocation inhibitor, and lenacapavir, a capsid inhibitor, is being investigated as a weekly oral HIV‐1 treatment.
Jing Niu, Haeyoung Zhang, John Ling, Sharline Madera, Nerissa Kwok, Steve West, Diane Longo, Gillian Gillespie, Cyril Llamoso, Dhananjay D. Marathe   +9 more
wiley   +1 more source

Pulse waveform analysis in Zambian adults living with HIV on antiretroviral therapy: A cross-sectional study of vascular dysfunction. [PDF]

Physiol Rep
Chikopela T, Kaluba L, Mwaanga S, Goma FM.   +3 more
europepmc   +1 more source

Acceptability and Preferences of Long‐Acting Injectable Pre‐Exposure Prophylaxis and Antiretroviral Therapy Among Men Who Have Sex With Men and People Who Inject Drugs in India: Insights for Future Implementation

Journal of the International AIDS Society, Volume 29, Issue 5, May 2026.
ABSTRACT Introduction Long‐acting injectable (LAI) antiretroviral therapy (ART) and pre‐exposure prophylaxis (PrEP) have significant potential to impact the HIV epidemic, but there is little data on the acceptability of these newer technologies among people who inject drugs (PWID) and men who have sex with men (MSM) in low‐resource settings.
Allison M. McFall, Talia A. Loeb, Jiban J. Baishya, Ashwini Kedar, Archit Sinha, A. K. Srikrishnan, Sunil S. Solomon, Gregory M. Lucas, Shruti H. Mehta   +8 more
wiley   +1 more source

Differences between different antiretroviral therapy regimens switching patterns among people living with HIV. [PDF]

BMC Public Health
Zhang H, Su Y, Yu Y, Li Z, Xi Y, Wang A, Han J, Zhao H.   +7 more
europepmc   +1 more source

Antiretroviral Therapy [PDF]

, 2007
openaire   +1 more source

Towards More Accessible and More Inclusive PrEP to Break the Cycle of HIV in France

Journal of the International AIDS Society, Volume 29, Issue 5, May 2026.
ABSTRACT Introduction Pre‐exposure prophylaxis (PrEP) represents a major advance in HIV prevention, but its rollout in France remains limited, particularly among women, migrants and socially vulnerable populations. Despite full reimbursement by the national health system, oral PrEP is still rarely prescribed outside hospital settings, hindered by ...
Jade Ghosn, Marie‐Laure Chaix
wiley   +1 more source

Scaling Up HIV Self‐Testing in Africa: Insights From National Programmatic Data in Eight Countries

Journal of the International AIDS Society, Volume 29, Issue 5, May 2026.
ABSTRACT Introduction Evidence from routine, national programme data on HIV self‐testing (HIVST) scale‐up is limited. This study examines HIVST scale‐up in eight African countries, describing how HIVST has been integrated into testing strategies and how testing coverage, test positivity, and linkage to antiretroviral therapy (ART) have evolved ...
Adrien Allorant, Anne Bekelynck, Aliza Monroe‐Wise, Carlota Baptista da Silva, Thato Chidarikire, Olanrewaju Edun, Leonid Joaquim, Christine Kisia, Joseph Larmarange, Johnson John Lyimo, Juma McOllogi James, Christine Musanhu, Getrude Ncube, Isabel Sathane, Arlette Simo‐Fotso, Geoffrey Taasi, Cheryl Case Johnson   +16 more
wiley   +1 more source

Transcriptional response to combination antiretroviral therapy predicts side effects and novel targets. [PDF]

Front Pharmacol
Lachmann A, Amadori L, Nicoletti P, Crane HM, Giannarelli C, Ma'ayan A, Peter I.   +6 more
europepmc   +1 more source